Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
8445769 | European Journal of Cancer | 2012 | 9 Pages |
Abstract
Exclusive nuclear localisation of IGF-1R is an easily testable biomarker associated with a better PFS and OS for patients treated with IGF-1R Ab therapy. Nuclear localisation of IGF-1R in tumour cells might be a hallmark of pathway activation.
Keywords
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cancer Research
Authors
Irène Asmane, Emmanuel Watkin, Laurent Alberti, Adeline Duc, Perrine Marec-Berard, Isabelle Ray-Coquard, Philippe Cassier, Anne-Valérie Decouvelaere, Dominique Ranchère, Jean-Emmanuel Kurtz, Jean-Pierre Bergerat, Jean-Yves Blay,